Trends is free while in Beta
Discover Trends in Pharma
We surface rapidly growing trends in Pharma before they take off.
Surging
5 Years
health
Pharma
Growth (5yr)
Show
trends
90
Retatrutide
301,000
vol/mo
6448%
(5y)
934%
(1y)
91%
(3mo)
Radioligand
590
vol/mo
1098%
(5y)
260%
(1y)
52%
(3mo)
Tesamorelin
74,000
vol/mo
910%
(5y)
381%
(1y)
87%
(3mo)
Peptide Therapy
14,800
vol/mo
235%
(5y)
195%
(1y)
51%
(3mo)
Semaglutide
450,000
vol/mo
230%
(5y)
-16%
(1y)
28%
(3mo)
Biomedicines
390
vol/mo
156%
(5y)
67%
(1y)
104%
(3mo)
SGLT2 Inhibitor
40,500
vol/mo
124%
(5y)
124%
(1y)
89%
(3mo)
Tranexamic Acid
110,000
vol/mo
60%
(5y)
45%
(1y)
33%
(3mo)
Ring Therapeutics
590
vol/mo
9999%+
(5y)
4743%
(1y)
209%
(3mo)
Amitriptyline Hydrochloride
12,100
vol/mo
9999%+
(5y)
612%
(1y)
-64%
(3mo)
Glucagon-Like Peptide-1
823,000
vol/mo
9999%+
(5y)
327%
(1y)
52%
(3mo)
Enteric Coating
6,600
vol/mo
9999%+
(5y)
251%
(1y)
44%
(3mo)
Trifarotene
2,400
vol/mo
9999%+
(5y)
100%
(1y)
57%
(3mo)
MoMa Therapeutics
880
vol/mo
9999%+
(5y)
9999%+
(1y)
9999%+
(3mo)
Navitoclax
590
vol/mo
9999%+
(5y)
9999%+
(1y)
263%
(3mo)
Cannabigerol
1,000
vol/mo
9999%+
(5y)
9999%+
(1y)
9999%+
(3mo)
Capstan Therapeutics
2,900
vol/mo
9999%+
(5y)
9999%+
(1y)
9999%+
(3mo)